Table 2.
clinical characteristics of respondents on HAART, Cross River State, 2017
| Variables | Frequency (N=999) | Percentage (100%) |
|---|---|---|
| Duration of treatment (months) | ||
| <12 months | 82 | 8.2 |
| 12-24 months | 144 | 14.4 |
| >24 months | 773 | 77.4 |
| HAART regimen | ||
| First line | 842 | 84.3 |
| Second line | 157 | 15.7 |
| HAART dosing | ||
| Once | 515 | 51.6 |
| Twice | 484 | 48.4 |
| Number of pills per day | ||
| 1 | 497 | 49.8 |
| 2 | 495 | 49.5 |
| ≥3 | 7 | 0.7 |
| Number of tablets missed/week | ||
| 0 | 541 | 54.2 |
| 1-2 | 439 | 43.9 |
| ≥3 | 19 | 1.9 |
| Fluid and food restrictions | ||
| No | 995 | 99.6 |
| Yes | 4 | 0.4 |
| Encountered side effects | ||
| No | 956 | 95.7 |
| Yes | 43 | 4.3 |
| Drug refill | ||
| ≤1 monthly | 160 | 16.0 |
| 2 monthly | 743 | 74.4 |
| 3 monthly | 96 | 9.6 |
| Transport cost to HF | ||
| ≤ ₦ 500 (USD 1.1) | 591 | 59.2 |
| > ₦ 500 (USD 1.1) | 408 | 40.8 |
| CD4 count | ||
| < 500 | 592 | 59.3 |
| ≥ 500 | 407 | 40.7 |
HAART: highly active antiretroviral therapy; HF: health facility